Pb1788 B‐symptoms, Performance Status, and Response to First Therapy as Survival Predictive Factors for Peripheral T‐cell Lymphoma at Progression/Relapse: A Single Institute Analysis
Abstract:Background: Primary mediastinal B-cell lymphoma (PMBCL) is a unique entity of non-Hodgkin lymphoma with distinct clinical and biological features. Several different chemoimmunotherapy approaches have been studied, mostly in retrospective case series, without reaching a consensus on the optimal upfront treatment. A phase 2 study, published by Dunleavy et. al. (NEJM 368, 1408(NEJM 368, -1416(NEJM 368, , 2013, demonstrated excellent survival outcomes after R-DAEPOCH without consolidative radiotherapy in 51 pati… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.